A differential regulatory T cell signature distinguishes the immune landscape of COVID-19 hospitalized patients from those hospitalized with other respiratory viral infections
Sarah C. Vick(Fred Hutch Cancer Center), Jennifer M. Lund(University of Washington)
Cited by 11
Related Papers
Anti–PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells
|The Journal of Immunology|2021|25
Memory T cells possess an innate-like function in local protection from mucosal infection
|Journal of Clinical Investigation|2023|23